These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25677585)

  • 1. Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review.
    Sorbi F; Prosperi P; Villanucci A; Berti V; Sisti G; Fambrini M
    Gynecol Obstet Invest; 2015; 80(4):265-71. PubMed ID: 25677585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report.
    Yasuda K; Yoshimura T; Kitade H; Yanagida H; Hosaka N
    J Med Case Rep; 2018 May; 12(1):132. PubMed ID: 29759073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique.
    Gallotta V; Nero C; Lodoli C; Chiantera V; Pacelli F; Fagotti A; Costantini B; Scambia G
    J Minim Invasive Gynecol; 2016; 23(3):425-8. PubMed ID: 26776676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Sep; 35(9):5097-101. PubMed ID: 26254413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancer.
    Otrock ZK; Seoud MA; Khalifeh MJ; Makarem JA; Shamseddine AI
    Int J Gynecol Cancer; 2006; 16(5):1933-5. PubMed ID: 17009994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solitary parenchymal splenic recurrence of ovarian adenocarcinoma: a case report and review of the literature.
    Tserkezoglou A; Kontou S; Hatjieleftheriou G; Nikolaidou ME; Plataniotis G; Apostolikas N; Magiakos G
    Anticancer Res; 2005; 25(2B):1471-6. PubMed ID: 15865107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.
    Xiang L; Tu Y; He T; Shen X; Li Z; Wu X; Yang H
    J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic splenectomy for secondary cytoreduction of ovarian cancer in a woman with localized splenic recurrence.
    Acosta-Torres S; Fader AN
    Gynecol Oncol; 2020 Mar; 156(3):744-745. PubMed ID: 31955860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary splenic recurrence of epithelial ovarian cancer: a case report and review.
    Lauro S; Trasatti L; Capalbo C; Conti A; Ricci F; Mingazzini PL; Vecchione A
    Anticancer Res; 2002; 22(6B):3643-5. PubMed ID: 12552970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy in recurrent epithelial ovarian cancer.
    Gemignani ML; Chi DS; Gurin CC; Curtin JP; Barakat RR
    Gynecol Oncol; 1999 Mar; 72(3):407-10. PubMed ID: 10053114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand-assisted laparoscopic splenectomy for isolated splenic metastasis from an ovarian carcinoma: a case report with review of the literature.
    Klinger PJ; Smith SL; Abendstein BJ; Hinder RA
    Surg Laparosc Endosc; 1998 Feb; 8(1):49-54. PubMed ID: 9488571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.
    Fagotti A; Costantini B; Gallotta V; Cianci S; Ronsini C; Petrillo M; Pacciani M; Scambia G; Fanfani F
    J Minim Invasive Gynecol; 2015; 22(3):428-32. PubMed ID: 25461683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer.
    Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N
    Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary splenic metastasis from ovarian cancer successfully treated by hand-assisted laparoscopic splenectomy: report of a case.
    Yano H; Iwazawa T; Kinuta M; Nakano Y; Tono T; Matsui S; Kanoh T; Monden T
    Surg Today; 2002; 32(8):750-2. PubMed ID: 12181732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary recurrent metastasis of epithelial ovarian cancer in the spleen.
    Farias-Eisner R; Braly P; Berek JS
    Gynecol Oncol; 1993 Mar; 48(3):338-41. PubMed ID: 8462900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy for solitary splenic metastasis of ovarian cancer.
    Koh YS; Kim JC; Cho CK
    BMC Cancer; 2004 Dec; 4():96. PubMed ID: 15615591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Splenectomy in epithelial ovarian cancer: analysis of 32 cases].
    Zheng AW; Zheng F; Chen YQ; Zhu HN; Qian JH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):197-200. PubMed ID: 18788569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.
    Tanner EJ; Long KC; Feffer JB; Leitao MM; Abu-Rustum NR; Barakat RR; Chi DS; Gardner GJ
    Gynecol Oncol; 2013 Jan; 128(1):28-33. PubMed ID: 23017819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique.
    Macciò A; Sanna E; Lavra F; Chiappe G; Petrillo M; Madeddu C
    BMC Surg; 2021 Oct; 21(1):380. PubMed ID: 34711237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.